About
▼
Mission
Technology
Team
Investors
Technology
▼
Technology Story
How It Works
Targeted Impact
Applications
Pipeline
▼
Development
Pipeline Objectives
Featured Publications
News
▼
Press Releases
Media Coverage
Events
Logo
Partners
Careers
▼
Open Positions
Contact
▼
Legal
Search
Toggle navigation
About
Mission
Technology
Team
Investors
Technology
Technology Story
How It Works
Targeted Impact
Applications
Pipeline
Development
Pipeline Objectives
Featured Publications
News
Press Releases
Media Coverage
Events
Logo
Partners
Careers
Open Positions
Contact
Legal
Search
how can we help?
Search for:
Search
DNA Damage Response Therapeutics Summit
Post navigation
Next Post
Next
AACR 2019 Poster – Tumor-selective CBX-11 (alphalex™-rucaparib) allows full dose co-administration with chemotherapy, enabling synergistic efficacy in HRD negative tumors
